<DOC>
	<DOCNO>NCT02311946</DOCNO>
	<brief_summary>This study investigate whether concurrent administration rabeprazole , antacid know proton pump inhibitor , alters absorption drug palbociclib give one six experimental formulation .</brief_summary>
	<brief_title>A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib</brief_title>
	<detailed_description>This 6 cohort study investigate one experimental formulation palbociclib six cohort 10 healthy subject . Each cohort receive two treatment fixed-sequence . In Period 1 , subject receive single 125mg dose palbociclib alone undergo serial pharmacokinetic blood sample 120 hour post-dose . In Period 2 , subject receive daily 40mg dos Rabeprazole 7 consecutive day , approximately 4 hour Day 7 rabeprazole dose subject receive single 125mg dose palbociclib . Subjects undergo serial pharmacokinetic blood sample 120 hour post-dose .</detailed_description>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<mesh_term>Antacids</mesh_term>
	<criteria>Healthy Male Female nonchildbearing potential , Having body weight &gt; 50 kg Having bopy mass index ( BMI ) 17.5 30.5 kg/m2 . Any condition possibly affect drug absorption ( eg , gastrectomy ) A positive urine drug cotinine test A know history hypersensitivity palbociclib A supine systolic blood pressure &gt; 140 mmHg , QTc &gt; 450 msec .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Palbociclib , Rabeprazole , Proton Pump Inhibitor , Drug Interaction Study , DDI</keyword>
</DOC>